Immunogenetics of CNS Tumors

Central nervous system (CNS) tumors have a unique tumor immune microenvironment, where immune cells can play a role in disease progression and resistance to therapy. Studying the immunogenetics of these cells can uncover mechanisms underlying their role in CNS tumors. Here is the latest research.

December 7, 2018
Open Access

Pseudoprogression: fact or wishful thinking in neuro-oncology?

The Lancet Oncology
David A Reardon, Michael Weller
February 29, 2020

Glucocorticoids and immune checkpoint inhibitors in glioblastoma

Journal of Neuro-oncology
William J Kelly, Mark R Gilbert
July 20, 2019

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

Matthew J FrigaultMarcela V Maus
October 17, 2018

Inhibiting the kynurenine pathway in spinal cord injury: Multiple therapeutic potentials?

Neural Regeneration Research
Kelly R Jacobs, David B Lovejoy
September 14, 2019
Comment / Editorial
Open Access

The CNS can be a safe space for CARs

Carlos Almeida Ramos
June 22, 2020

Update on Pediatric Brain Tumors: the Molecular Era and Neuro-immunologic Beginnings

Current Neurology and Neuroscience Reports
Elizabeth Duke, Roger J Packer
July 4, 2020

Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas

Current Oncology Reports
Christine Cordova, Sylvia C Kurz
December 8, 2019

Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas

Virchows Archiv : an International Journal of Pathology
Melissa AlameVanessa Szablewski
July 12, 2019

Primary central nervous system lymphoma: Novel precision therapies

Critical Reviews in Oncology/hematology
Patrizia MondelloFrancesco Bertoni
October 12, 2018
Open Access

Primary central nervous system lymphoma

Therapeutic Advances in Neurological Disorders
Sarah LöwTracy T Batchelor
February 11, 2020

Tumor antigens in glioma

Seminars in Immunology
Takahide NejoHideho Okada

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Cognitive Decline: Environmental And Genetic Factors

This feed focuses on the role of environmental and genetic factors including environmental policies, disease susceptibility, and socioeconomic status on cognitive decline. Here is the latest research.

Epigenetic Changes in Pain

Targeted epigenetic interventions provide the tools to prevent nociceptive sensitization, mood-related symptoms, and other adaptations that occur in response to injury or inflammation, which will facilitate pain management and improve treatment efficacy in many chronic pain conditions. Here is the latest research on the epigenetics changes in pain.

Epigenetic Regulation of Microglia Functions

Microglial cells are instrumental in the maintenance of homeostasis in the CNS and can contribute to neurodegenerative disorders. Epigenetic mechanisms and transcriptional regulation may be potential therapeutic targets for their activation or suppression. Discover the latest research on epigenetic regulation of microglial functions here.

Gene-Environment Interaction & Behaviour

Gene-environment interaction is when two different genotypes respond to environmental variation in different ways.Genes and environment interact to form an individual's personality. Abnormal or extreme behaviour could thus be explained by hereditary factors in combination with poor environmental conditions.

Genetic Influences on Brain Development

The genetic landscape of an individual can have drastic effects on brain development and brain developmental disorders. Discover the latest research here.

Genetic Networks Underlying Habituation

Habituation, the gradual waning of an evoked behavioral response with repeated stimulation, is a basic and universal form of learning. This feed explores the genetic networks that are involved in the occurence of habituation.

Genetic Screens in iPSC-Derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Genetics of Pain

Subtle changes in DNA could partly explain the variation in individual differences in pain. There is growing evidence that a number of genes play a critical role in determining pain sensitivity, pain reporting and susceptibility to developing chronic pain and their response to surgical outcomes primarily, pain.

Neurogenetic Disorders

Neurogenetic disorders are caused by a defect in one or more genes affecting the differentiation and function of the neuroectoderm and its derivatives. Here is the latest research on neurogenetic disorders

© 2020 Meta ULC. All rights reserved